{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T04:26:34Z","timestamp":1783743994452,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,10]],"date-time":"2024-03-10T00:00:00Z","timestamp":1710028800000},"content-version":"vor","delay-in-days":344,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.bcp.2023.115486","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T21:22:55Z","timestamp":1678224175000},"page":"115486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Oral mometasone furoate administration preserves anti-inflammatory action with fewer metabolic adverse effects in rats"],"prefix":"10.1016","volume":"210","author":[{"given":"Priscila L.","family":"Zimath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena S.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciel A.","family":"Bruxel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Rafacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2023.115486_b0005","first-page":"121","article-title":"Functional and molecular aspects of glucocorticoids in the endocrine pancreas and glucose homeostasis","author":"Rafacho","year":"2012","journal-title":"State Art Therapeut. Endocrinol."},{"key":"10.1016\/j.bcp.2023.115486_b0010","doi-asserted-by":"crossref","DOI":"10.3390\/metabo6030024","article-title":"Impact of glucocorticoid excess on glucose tolerance: clinical and preclinical evidence","volume":"6","author":"Pasieka","year":"2016","journal-title":"Metabolites"},{"key":"10.1016\/j.bcp.2023.115486_b0015","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3803\/EnM.2017.32.2.180","article-title":"Glucocorticoid-induced diabetes mellitus: an important but overlooked problem","volume":"32","author":"Suh","year":"2017","journal-title":"Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2023.115486_b0020","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.clim.2017.07.023","article-title":"Will we ever have better glucocorticoids?","volume":"186","author":"Buttgereit","year":"2018","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.bcp.2023.115486_b0025","doi-asserted-by":"crossref","first-page":"e53936","DOI":"10.1371\/journal.pone.0053936","article-title":"Glucocorticoid repression of inflammatory gene expression shows differential responsiveness by transactivation- and transrepression-dependent mechanisms","volume":"8","author":"King","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2023.115486_b0030","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.4049\/jimmunol.166.3.1975","article-title":"Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity","volume":"166","author":"Belvisi","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2023.115486_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2017.00016","article-title":"New insights in glucocorticoid receptor signaling-more than just a ligand-binding receptor","volume":"8","author":"Scheschowitsch","year":"2017","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.bcp.2023.115486_b0040","doi-asserted-by":"crossref","unstructured":"S.V. Onrust, H.M. Lamb, Mometasone furoate, Drugs 56 (1998) 725\u2013745. <https:\/\/doi.org\/10.2165\/00003495-199856040-00018>.","DOI":"10.2165\/00003495-199856040-00018"},{"key":"10.1016\/j.bcp.2023.115486_b0045","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3109\/08923970902874693","article-title":"Dissociation of local anti-inflammatory effect and systemic effects of mometasone furoate in mice","volume":"31","author":"Ogawa","year":"2009","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.bcp.2023.115486_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep14086","article-title":"The glucocorticoid mometasone furoate is a novel FXR ligand that decreases inflammatory but not metabolic gene expression","volume":"5","author":"Bijsmans","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2023.115486_b0055","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1177\/009127000004001107","article-title":"Bioavailability and metabolism of mometasone furoate following administration by metered-dose and dry-powder inhalers in healthy human volunteers","volume":"40","author":"Affrime","year":"2000","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115486_b0060","unstructured":"National Research Council. Guide for the Care and Use of Laboratory Animals. vol. Eighth Edition, 2010."},{"key":"10.1016\/j.bcp.2023.115486_b0065","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.diabres.2009.11.008","article-title":"Involvement of the cholinergic pathway in glucocorticoid-induced hyperinsulinemia in rats","volume":"87","author":"Angelini","year":"2010","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.bcp.2023.115486_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2014.09.024","article-title":"JNK and IKK\u03b2 phosphorylation is reduced by glucocorticoids in adipose tissue from insulin-resistant rats","volume":"145","author":"Motta","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bcp.2023.115486_b0075","article-title":"Impact of glucocorticoid treatment before pregnancy on glucose homeostasis of offspring exposed to glucocorticoid in adult life","volume":"237","author":"da Silva","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2023.115486_b0080","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1016\/0006-2952(87)90327-3","article-title":"SK&F 86002: a structurally novel anti-inflammatory agent that inhibits lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid","volume":"36","author":"Griswold","year":"1987","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115486_b0085","unstructured":"A. Chassaing, V.K. Malleshappa. Dextran Sulfate Sodium (DSS)-Induced Colitis in Mice, NIH Public Access 18 (2013) 1199\u2013216. <https:\/\/doi.org\/10.1002\/0471142735.im1525s104.Dextran>."},{"key":"10.1016\/j.bcp.2023.115486_b0090","doi-asserted-by":"crossref","unstructured":"L.M. da Silva, J.A.M. Farias, T. Boeing, L.B. Somensi, A.P. Beber, B.J. Cury et al., Hydroalcoholic Extract from Inflorescences of Achyrocline satureioides (Compositae) Ameliorates Dextran Sulphate Sodium-Induced Colitis in Mice by Attenuation in the Production of Inflammatory Cytokines and Oxidative Mediators. Evidence-Based Complementary and Alternative Medicine 2016 (2016). <https:\/\/doi.org\/10.1155\/2016\/3475356>.","DOI":"10.1155\/2016\/3475356"},{"key":"10.1016\/j.bcp.2023.115486_b0095","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ejphar.2017.05.012","article-title":"Protective role of cGMP in early sepsis","volume":"807","author":"Kovalski","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2023.115486_b0100","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00011-003-1207-3","article-title":"Impairment of inflammatory response in adult rats submitted to maternal undernutrition during early lactation: role of insulin and glucocorticoid","volume":"52","author":"Barja-Fidalgo","year":"2003","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.bcp.2023.115486_b0105","article-title":"Impact of combined long-term fructose and prednisolone intake on glucose and lipid homeostasis in rats: benefits of intake interruption or fish oil administration","volume":"90","author":"dos Santos","year":"2021","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.bcp.2023.115486_b0110","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1152\/jappl.1970.28.2.234","article-title":"Determination of glycogen in small tissue samples","volume":"28","author":"Lo","year":"1970","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.bcp.2023.115486_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119509","article-title":"Reduced insulin sensitivity and increased \u03b2\/\u03b1 cell mass is associated with reduced hepatic insulin-degrading enzyme activity in pregnant rats","volume":"277","author":"Taschetto","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2023.115486_b0120","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1001\/jama.1955.02950210007003","article-title":"Studies on metacortandralone and metacortandracin in rheumatoid arthritis: antirheumatic potency, metabolic effects, and hormonal properties","volume":"157","author":"Bunim","year":"1955","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.bcp.2023.115486_b0125","first-page":"118","article-title":"Pathway to carrageenan-induced inflammation in the hind limb of the rat","volume":"46","author":"Vinegar","year":"1987","journal-title":"Fed. Proc."},{"key":"10.1016\/j.bcp.2023.115486_b0130","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nri.2017.1","article-title":"Immune regulation by glucocorticoids","volume":"17","author":"Cain","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115486_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-03696-8","article-title":"Sex differences in prostaglandin biosynthesis in neutrophils during acute inflammation","volume":"7","author":"Pace","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2023.115486_b0140","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.intimp.2017.05.039","article-title":"Chronic dexamethasone treatment results in hippocampal neurons injury due to activate NLRP1 inflammasome in vitro","volume":"49","author":"Zhang","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2023.115486_b0145","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/0006-2952(88)90230-4","article-title":"Reversal of the anti-inflammatory effects of dexamethasone by the glucocorticoid antagonist RU 38486","volume":"37","author":"Peers","year":"1988","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115486_b0150","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1465-9921-5-7","article-title":"Significant receptor affinities of metabolites and a degradation product of mometasone furoate","volume":"5","author":"Valotis","year":"2004","journal-title":"Respir. Res."},{"key":"10.1016\/j.bcp.2023.115486_b0155","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nprot.2007.41","article-title":"Chemically induced mouse models of intestinal inflammation","volume":"2","author":"Wirtz","year":"2007","journal-title":"Nat. Protoc."},{"issue":"6","key":"10.1016\/j.bcp.2023.115486_b0160","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1007\/s00125-008-0995-y","article-title":"Evidence that autonomic mechanisms contribute to the adaptive increase in insulin secretion during dexamethasone-induced insulin resistance in humans","volume":"1","author":"Ahr\u00e9n","year":"2008","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.bcp.2023.115486_b0165","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/oby.2003.90","article-title":"Metabolic adaptations to dexamethasone-induced insulin resistance in healthy volunteers","volume":"11","author":"Nicod","year":"2003","journal-title":"Obes. Res."},{"issue":"2","key":"10.1016\/j.bcp.2023.115486_b0170","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/00006676-200103000-00007","article-title":"Beta cell adaptation to dexamethasone-induced insulin resistance in rats involves increased glucose responsiveness but not glucose effectiveness","volume":"22","author":"Karlsson","year":"2001","journal-title":"Pancreas"},{"issue":"9","key":"10.1016\/j.bcp.2023.115486_b0175","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1053\/meta.2001.25803","article-title":"Dexamethasone treatment induces long-lasting hyperleptinemia and anorexia in old rats","volume":"50","author":"Caldefie-Ch\u00e9zet","year":"2001","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.bcp.2023.115486_b0180","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1055\/s-0030-1269896","article-title":"Morphofunctional alterations in endocrine pancreas of short- and long-term dexamethasone-treated rats","volume":"43","author":"Rafacho","year":"2011","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.bcp.2023.115486_b0185","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nm.3760","article-title":"Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance","volume":"21","author":"Fang","year":"2015","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.bcp.2023.115486_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1073\/pnas.0506982103","article-title":"Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice","volume":"103","author":"Zhang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2023.115486_b0195","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.2337\/diabetes.50.6.1344","article-title":"Decreased susceptibility to fatty acid-induced peripheral tissue insulin resistance in women","volume":"50","author":"Frias","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2023.115486_b0200","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1139\/cjpp-2014-0259","article-title":"Age- and gender-related changes in glucose homeostasis in glucocorticoid-treated rats","volume":"92","author":"dos Santos","year":"2014","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115486_b0205","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.2337\/diabetes.51.6.1907","article-title":"Female rats do not exhibit free fatty acid-induced insulin resistance","volume":"51","author":"Hevener","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2023.115486_b0210","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1210\/me.2009-0287","article-title":"Rapid regulation of K(ATP) channel activity by 17beta-estradiol in pancreatic beta-cells involves the estrogen receptor beta and the atrial natriuretic peptide receptor","volume":"23","author":"Soriano","year":"2009","journal-title":"Mol. Endocrinol."},{"issue":"3","key":"10.1016\/j.bcp.2023.115486_b0215","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1748-1716.2010.02146.x","article-title":"The adaptive compensations in endocrine pancreas from glucocorticoid-treated rats are reversible after the interruption of treatment","volume":"200","author":"Rafacho","year":"2010","journal-title":"Acta Physiol."},{"key":"10.1016\/j.bcp.2023.115486_b0220","doi-asserted-by":"crossref","unstructured":"A. al Shoyaib, S.R. Archie, V.T. Karamyan, Intraperitoneal route of drug administration: should it be used in experimental animal studies? Pharm. Res. 37 (2020). <https:\/\/doi.org\/10.1007\/S11095-019-2745-X>.","DOI":"10.1007\/s11095-019-2745-x"},{"key":"10.1016\/j.bcp.2023.115486_b0225","first-page":"600","article-title":"Administration of substances to laboratory animals: routes of administration and factors to consider","volume":"50","author":"Turner","year":"2011","journal-title":"J. Am. Assoc. Lab. Anim. Sci."},{"key":"10.1016\/j.bcp.2023.115486_b0230","article-title":"Comparison between intraperitoneal and oral methylphenidate administration: a microdialysis and locomotor activity study","volume":"295","author":"Gerasimov","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2023.115486_b0235","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.2147\/IJN.S32880","article-title":"Enhanced oral bioavailability of docetaxel by lecithin nanoparticles: preparation, in vitro, and in vivo evaluation","volume":"7","author":"Hu","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bcp.2023.115486_b0240","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1211\/0022357001773670","article-title":"Oral, intraperitoneal and intravenous pharmacokinetics of deramciclane and its N-desmethyl metabolite in the rat","volume":"52","author":"Nemes","year":"2000","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115486_b0245","doi-asserted-by":"crossref","first-page":"3257812","DOI":"10.1155\/2018\/3257812","article-title":"Prevention of elevation in plasma triacylglycerol with high-dose bezafibrate treatment abolishes insulin resistance and attenuates glucose intolerance induced by short-term treatment with dexamethasone in rats","volume":"2018","author":"In\u00e1cio","year":"2018","journal-title":"Int. J. Endocrinol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115486_b0250","doi-asserted-by":"crossref","first-page":"E681","DOI":"10.1152\/ajpendo.90931.2008","article-title":"High doses of dexamethasone induce increased beta-cell proliferation in pancreatic rat islets","volume":"296","author":"Rafacho","year":"2009","journal-title":"Am. J. Phys. Endocrinol. Metab."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223000771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223000771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T18:20:21Z","timestamp":1736360421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295223000771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":50,"alternative-id":["S0006295223000771"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115486","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral mometasone furoate administration preserves anti-inflammatory action with fewer metabolic adverse effects in rats","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115486","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115486"}}